167 related articles for article (PubMed ID: 9180349)
1. Involvement of cytochrome P450 3A4 in N-dealkylation of buprenorphine in human liver microsomes.
Iribarne C; Picart D; Dréano Y; Bail JP; Berthou F
Life Sci; 1997; 60(22):1953-64. PubMed ID: 9180349
[TBL] [Abstract][Full Text] [Related]
2. Involvement of cytochrome P450 3A4 enzyme in the N-demethylation of methadone in human liver microsomes.
Iribarne C; Berthou F; Baird S; Dréano Y; Picart D; Bail JP; Beaune P; Ménez JF
Chem Res Toxicol; 1996 Mar; 9(2):365-73. PubMed ID: 8839037
[TBL] [Abstract][Full Text] [Related]
3. Involvement of cytochrome P450 3A enzyme family in the major metabolic pathways of toremifene in human liver microsomes.
Berthou F; Dreano Y; Belloc C; Kangas L; Gautier JC; Beaune P
Biochem Pharmacol; 1994 May; 47(10):1883-95. PubMed ID: 8204106
[TBL] [Abstract][Full Text] [Related]
4. Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions.
Labroo RB; Paine MF; Thummel KE; Kharasch ED
Drug Metab Dispos; 1997 Sep; 25(9):1072-80. PubMed ID: 9311623
[TBL] [Abstract][Full Text] [Related]
5. Evidence for cytochrome P450 2A6 and 3A4 as major catalysts for N'-nitrosonornicotine alpha-hydroxylation by human liver microsomes.
Patten CJ; Smith TJ; Friesen MJ; Tynes RE; Yang CS; Murphy SE
Carcinogenesis; 1997 Aug; 18(8):1623-30. PubMed ID: 9276639
[TBL] [Abstract][Full Text] [Related]
6. Human buprenorphine N-dealkylation is catalyzed by cytochrome P450 3A4.
Kobayashi K; Yamamoto T; Chiba K; Tani M; Shimada N; Ishizaki T; Kuroiwa Y
Drug Metab Dispos; 1998 Aug; 26(8):818-21. PubMed ID: 9698298
[TBL] [Abstract][Full Text] [Related]
7. Interaction of methadone with substrates of human hepatic cytochrome P450 3A4.
Iribarne C; Dréano Y; Bardou LG; Ménez JF; Berthou F
Toxicology; 1997 Feb; 117(1):13-23. PubMed ID: 9020195
[TBL] [Abstract][Full Text] [Related]
8. Novel metabolites of buprenorphine detected in human liver microsomes and human urine.
Chang Y; Moody DE; McCance-Katz EF
Drug Metab Dispos; 2006 Mar; 34(3):440-8. PubMed ID: 16381669
[TBL] [Abstract][Full Text] [Related]
9. Catalytic role of cytochrome P4502B6 in the N-demethylation of S-mephenytoin.
Heyn H; White RB; Stevens JC
Drug Metab Dispos; 1996 Sep; 24(9):948-54. PubMed ID: 8886603
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of FK506, a potent immunosuppressive agent, by cytochrome P450 3A enzymes in rat, dog and human liver microsomes.
Shiraga T; Matsuda H; Nagase K; Iwasaki K; Noda K; Yamazaki H; Shimada T; Funae Y
Biochem Pharmacol; 1994 Feb; 47(4):727-35. PubMed ID: 7510480
[TBL] [Abstract][Full Text] [Related]
11. Identification of human liver cytochrome P450 isoforms involved in the in vitro metabolism of cyclobenzaprine.
Wang RW; Liu L; Cheng H
Drug Metab Dispos; 1996 Jul; 24(7):786-91. PubMed ID: 8818577
[TBL] [Abstract][Full Text] [Related]
12. Identification of human liver cytochrome P-450 3A4 as the enzyme responsible for fentanyl and sufentanil N-dealkylation.
Tateishi T; Krivoruk Y; Ueng YF; Wood AJ; Guengerich FP; Wood M
Anesth Analg; 1996 Jan; 82(1):167-72. PubMed ID: 8712396
[TBL] [Abstract][Full Text] [Related]
13. Catalytic role of cytochrome P4503A4 in multiple pathways of alfentanil metabolism.
Labroo RB; Thummel KE; Kunze KL; Podoll T; Trager WF; Kharasch ED
Drug Metab Dispos; 1995 Apr; 23(4):490-6. PubMed ID: 7600917
[TBL] [Abstract][Full Text] [Related]
14. Role of human cytochrome P450 3A4 and 3A5 in the metabolism of taxotere and its derivatives: enzyme specificity, interindividual distribution and metabolic contribution in human liver.
Shou M; Martinet M; Korzekwa KR; Krausz KW; Gonzalez FJ; Gelboin HV
Pharmacogenetics; 1998 Oct; 8(5):391-401. PubMed ID: 9825831
[TBL] [Abstract][Full Text] [Related]
15. The involvement of cytochrome P450 3A4 in the N-demethylation of L-alpha-acetylmethadol (LAAM), norLAAM, and methadone.
Moody DE; Alburges ME; Parker RJ; Collins JM; Strong JM
Drug Metab Dispos; 1997 Dec; 25(12):1347-53. PubMed ID: 9394023
[TBL] [Abstract][Full Text] [Related]
16. Nefazodone, meta-chlorophenylpiperazine, and their metabolites in vitro: cytochromes mediating transformation, and P450-3A4 inhibitory actions.
von Moltke LL; Greenblatt DJ; Granda BW; Grassi JM; Schmider J; Harmatz JS; Shader RI
Psychopharmacology (Berl); 1999 Jul; 145(1):113-22. PubMed ID: 10445380
[TBL] [Abstract][Full Text] [Related]
17. O-demethylation of epipodophyllotoxins is catalyzed by human cytochrome P450 3A4.
Relling MV; Nemec J; Schuetz EG; Schuetz JD; Gonzalez FJ; Korzekwa KR
Mol Pharmacol; 1994 Feb; 45(2):352-8. PubMed ID: 8114683
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 metabolic dealkylation of nine N-nitrosodialkylamines by human liver microsomes.
Bellec G; Dréano Y; Lozach P; Ménez JF; Berthou F
Carcinogenesis; 1996 Sep; 17(9):2029-34. PubMed ID: 8824531
[TBL] [Abstract][Full Text] [Related]
19. Human reductive halothane metabolism in vitro is catalyzed by cytochrome P450 2A6 and 3A4.
Spracklin DK; Thummel KE; Kharasch ED
Drug Metab Dispos; 1996 Sep; 24(9):976-83. PubMed ID: 8886607
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of levo-alpha-Acetylmethadol (LAAM) by human liver cytochrome P450: involvement of CYP3A4 characterized by atypical kinetics with two binding sites.
Oda Y; Kharasch ED
J Pharmacol Exp Ther; 2001 Apr; 297(1):410-22. PubMed ID: 11259570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]